Advertisement

Annals of Nuclear Medicine

, Volume 6, Issue 1, pp 43–49 | Cite as

Circulating myosin light chain I levels after coronary reperfusion: A comparison with myocardial necrosis evaluated from single photon emission computed tomography with pyrophosphate

  • Hiroshi Yoshida
  • Mamoru Mochizuki
  • Kazuyuki Sakata
  • Mitsuru Takezawa
  • Yasunori Matsumoto
  • Masami Yoshimura
  • Noriko Mori
  • Shoichi Yokoyama
  • Tsuneo Hoshino
  • Tsuneo Kaburagi
Original Article
  • 13 Downloads

Abstract

This study was performed to assess the influence of coronary reperfusion on the serial serum myosin light chain (LC)I levels and to evaluate the relationship between the peak LCI level and the infarct size calculated from single photon emission computed tomography (SPECT) with technetium-99m pyrophosphate (Tc-99m PYP) in 11 patients who underwent coronary reperfusion. Blood was drawn before reperfusion, immediately after reperfusion, and once a day for 14 days, to estimate the time course of serum LCI release. The infarct size estimated by Tc-99m PYP ranged from 7.3 to 62.4 ml. The LCI levels obtained before reperfusion were less than 2.5 ng/ml but those obtained immediately after reperfusion were much higher. The value ranged from 2.7 to 9.7 ng/ml and that expressed as a percentage of peak LCI (% peak LCI) ranged from 19 to 83%. Collateral circulation, reperfusion arrhythmia and the degree of residual stenosis had no influence upon the % peak LCI. The correlation between peak LCI levels and SPECT-determined infarct size was good, with a correlation of 0.76 (p< 0.01, regression line by least squares method y= −3.31+1.53x). Early serum LCI might be influenced by coronary reperfusion but the peak LCI value reflected acute myocardial necrosis in patients who underwent coronary reperfusion.

Key words

myosin light chain I coronary reperfusion myocardial necrosis 99mTc-PYP/201Tl dual SPECT 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Trahern CA, Gere JB, Krauth BH, et al: Clinical assessment of serum myosin light chains in the diagnosis of acute myocardial infarction.Am J Cardiol 41: 641–645, 1978PubMedCrossRefGoogle Scholar
  2. 2.
    Nagai R, Yamazaki M: Assessment of myocardial infarct size by serial changes in serum cardiac myosin light chain II in dogs.Jpn Circ J 45: 661–666, 1981PubMedGoogle Scholar
  3. 3.
    Katus HA, Yasuda T, Gold HK, et al: Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains.Am J Cardiol 54: 964–970, 1984PubMedCrossRefGoogle Scholar
  4. 4.
    Rosalki SB: An improved procedure for serum creatine phosphokinase determination.J Lab Clin Med 69: 696–705, 1967PubMedGoogle Scholar
  5. 5.
    Isobe M, Nagai R, Ueda S, et al: Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarctionCirculation 76: 1251–1261, 1987PubMedGoogle Scholar
  6. 6.
    Sobel BE, Bresnahaman GF, Shell WE, et al: Estimation of infarct size in man and its relation to prognosis.Circulation 46: 640–648, 1972PubMedGoogle Scholar
  7. 7.
    Vatner SF, Baig H, Manders WT, et al: Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase.J Clini Invest 61: 1048–1056, 1978CrossRefGoogle Scholar
  8. 8.
    The multicenter postinfarction research group: Risk stratification and survival after myocardial infarction.N Engl J Med 309: 331–336, 1983Google Scholar
  9. 9.
    Tamaki S, Nakajima H, Murakami T, et al: Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation to creatine kinase-MB release after myocardial infarction in man.Circulation 66: 994–1001, 1982PubMedGoogle Scholar
  10. 10.
    Holman BE, Goldhaber SZ, Kirsch CM, et al: Measurement of infarct size using single photon emission computed tomography and technetium-99m pyrophosphate: patient prognosis.Am J Cardiol 50: 503–511, 1982PubMedCrossRefGoogle Scholar
  11. 11.
    Jansen DE, Corbett JR., Wolfe CL, et al: Quantification of myocardial infarction: a comparison of single photon-emission computed tomography with pyrophosphate to serial plasma MB-creatine kinase measurements.Circulation 72: 327–333, 1985PubMedGoogle Scholar
  12. 12.
    Jansen DE, Corbett JR, Buja M, et al: Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate.Circulation 75: 611–617, 1987PubMedGoogle Scholar
  13. 13.
    Nagai R, Ueda S, Yazaki Y: Radioimmunoassay of cardiac myosin light chain II in the serum following experimental myocardial infarction.Biochem Biophys Res Commun 86: 683–688, 1979PubMedCrossRefGoogle Scholar
  14. 14.
    Katus HA, Diederich KW, Hoberg E, et al: Circulating cardiac myosin light chains in patients with angina at rest: identification of a high risk subgroup.J Am Coll Cardiol 11: 487–493, 1988PubMedCrossRefGoogle Scholar
  15. 15.
    Isobe M, Nagai R, Yamaoki K, et al: Quantification of myocardial infarct size after coronary reperfusion by serum cardiac myosin light chain II in conscious dog.Circ Res 65: 684–694, 1989PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Hiroshi Yoshida
    • 1
  • Mamoru Mochizuki
    • 2
  • Kazuyuki Sakata
    • 1
  • Mitsuru Takezawa
    • 2
  • Yasunori Matsumoto
    • 2
  • Masami Yoshimura
    • 2
  • Noriko Mori
    • 1
  • Shoichi Yokoyama
    • 1
  • Tsuneo Hoshino
    • 2
  • Tsuneo Kaburagi
    • 1
  1. 1.Department of CardiologyShizuoka General HospitalShizuokaJapan
  2. 2.Department of Nuclear MedicineShizuoka General HospitalShizuokaJapan

Personalised recommendations